Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

Proteros Biostructures GmbH. (5/24/11). "Press Release: Proteros and Institut Pasteur Korea Establish Discovery Services Collaboration in the Field of Infectious Diseases". Martinsried.

Organisations Organisation Proteros Biostructures GmbH
  Group Proteros (Group)
  Organisation 2 Institut Pasteur Korea (IP-Korea)
  Group Institut Pasteur
Products Product structure-based drug design
  Product 2 drug discovery services
Person Person D’Cruz, Cony (Proteros 201008– CBO + President Proteros US Inc before Evotec SVP North America)

Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K. Under this collaboration Proteros will apply its know-how, experience of structural analysis and its proprietary X-ray crystallography platform to support IP-K?s mission to develop therapeutics for infectious diseases.

Cony D'Cruz, Chief Business Officer of Proteros, stated, "Institut Pasteur Korea is a world class translational research institute, renowned as a centre of excellence in biomedical research and technology development with a clear focus on infectious and neglected disease. We welcome the opportunity for Proteros to contribute to these efforts."

Dr. Michel Liuzzi, Director, Early Discovery Program at IP-K, added "We are very pleased with the expertise and know-how of Proteros in providing timely X-ray crystallography support to our in-house drug discovery projects and we look forward to continue collaborating with Proteros in the future."

About Proteros:

Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. Proteros uses its technical expertise, industrial processes and unique technologies for crystallography, kinetic and thermodynamic profiling and fragment-based lead generation incorporating protein structure inspired compound and fragment libraries. The platform enables "knowledge driven lead engineering? to accelerate and improve protein structure analysis and structure-based drug discovery. Proteros complements its clients? internal capabilities with external expertise and access to flexible resources. Proteros currently provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia.

About Institut Pasteur Korea:

Institut Pasteur Korea (IP-K) is an independent non-profit institute founded in April, 2004 with a strategic focus on enabling technologies and therapeutic development in disease models pertaining to public health. IP-K has developed a novel research platform that combines chemical genomics with high content visual screening by bringing together the latest advances in biology, technology, and chemistry. The application of the platform technology in the fields of infectious disease and chronic illness allows basic science to be extended to drug discovery. In turn the application of functional genomics - using global siRNA - allows further elucidation of the basic molecular and genetic underpinnings of disease. Visit


Proteros biostructures GmbH
Kurt Herrenknecht, Ph.D.
Am Klopferspitz 19
82152 Martinsried
Phone: +49 (0) 89 7007 61 0

Institut Pasteur Korea
Jean Kim
Sampyeong-dong 696
Bundang-gu, Seongnam-si, Gyeonggi-do
Phone: +82 (0) 31 8018 8041

Record changed: 2019-06-09


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Proteros (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

» top